Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial. The Fox Medical Team's Dr. Mike Cirigliano joined Good Day to take a look ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...